MedPath

A clinical trial to study effects of homoeopathic medicine & integrative medicine(homoeopathy and modern medicine) in patients with metabolic syndrome.

Phase 2
Conditions
Health Condition 1: I10- Essential (primary) hypertensionHealth Condition 2: E782- Mixed hyperlipidemiaHealth Condition 3: E660- Obesity due to excess caloriesHealth Condition 4: E781- Pure hyperglyceridemia
Registration Number
CTRI/2024/04/066492
Lead Sponsor
Metropolitan Homoeopathic Medical College and Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

We will be considering patients who can satisfy any 3 out of these 5 criteria as per The National Cholesterol Education Program: Adult Treatment Panel III(NCEP: ATP III) later modified by American Heart Association(AHA) & National Heart, Lung and Blood Institute(NHLBI- 1)Abdominal obesity- = 102 cm (40 inches) in males and = 88 cm (35 inches) in females. 2)Hypertension- =130 mm Hg systolic blood pressure ; =85 mm Hg diastolic blood pressure or under antihypertensive drug treatment in a patient with a history of hypertension. 3)Hyperglycemia- =100 mg/dL or under drug treatment for elevated glucose. 4)Hypertriglyceridemia- =150 mg/dL (1.7mmol/ L) or under drug treatment for elevated triglycerides. 5)Low high density lipoprotien cholesterol levels- less than 40 mg/dL in males and less then 50 mg/dL in females or under drug treatment for reduced HDL-C levels

Exclusion Criteria

1) Patients suffering from AIDS, cancer along with metabolic syndrome are excluded.

2)Pregnant & lactating women are excluded.

3)Patients with life threatening diagnosed heart and neurological disorders.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath